Abingdon, United Kingdom

Shelley Anne Parrott

This inventor holds 5 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Disarm Therapeutics, Inc., Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shelley Anne Parrott. Retrieved from https://idiyas.com/inventor/shelley-anne-parrott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Shelley Anne Parrott: Innovator in Axonal Degeneration Research

Introduction

Shelley Anne Parrott is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of neuroscience, particularly in the area of axonal degeneration. With a total of five patents to her name, her work focuses on developing innovative compounds that can inhibit SARM1, a key player in axonal degeneration.

Latest Patents

Among her latest patents are "Indazole derivatives as inhibitors of SARM1" and "Inhibitors of SARM1." These patents provide valuable compounds and methods that are useful for inhibiting SARM1 and for treating and preventing axonal degeneration. Her research aims to offer new therapeutic options for conditions related to nerve damage.

Career Highlights

Shelley has worked with notable companies such as Disarm Therapeutics, Inc. and Padlock Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and to advance her research on SARM1 inhibitors.

Collaborations

Throughout her career, Shelley has collaborated with talented individuals, including Rajesh Devraj and Todd Bosanac. These partnerships have enriched her research and contributed to the development of her innovative solutions.

Conclusion

Shelley Anne Parrott is a trailblazer in the field of axonal degeneration research, with her patents paving the way for potential new treatments. Her dedication to innovation continues to inspire advancements in neuroscience.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…